Status:
COMPLETED
Combined Rehabilitation With ALA, ALC, Resveratrol and Vitamin D in Discogenic Sciatica in Young People
Lead Sponsor:
University of Palermo
Conditions:
Sciatic Radiculopathy
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The objective of this Interventional case-control clinical study is to evaluate the effectiveness of physiotherapy combined with the administration of Alpha Lipoic Acid, L-acetylcarnitine, Resvelatrol...
Eligibility Criteria
Inclusion
- age 18-45 years
- pain with NRS scale score between 5 and 7 points
- symptoms attributable to lumbosciatica which occurred no more than 4 weeks ago
- pharmacological wash out of NSAIDs and corticosteroids for at least a week
- presence of L4-L5, L5-S1 disc herniation diagnosed with lumbar MRI performed within 3 months
- absence of ongoing infectious episodes;
- written consent for participation in the study.
Exclusion
- Altered states of consciousness;
- Sciatica not of disc origin
- Neurological disorders
- Presence of scoliosis \>20° of Cobb
- Previous spinal surgery
- Pregnancy and/or breastfeeding
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 22 2023
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06078163
Start Date
July 1 2022
End Date
August 22 2023
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Functional Recovery and Rehabilitation Unit of the A.O.U.P. Paolo Giaccone
Palermo, Italy, 90127